Merck awarded $2.5 billion in dispute over Gilead drugs
Friday, December 16, 2016 - 14:11
in Health & Medicine
Gilead will appeal the latest verdict centered on the active ingredient of its breakthrough hepatitis C therapies
Updated by artificial intelligence Tue, 13 Jun 2023, 2:53:47 UTC Learn more
- Tell your friends
- Get science news via